Baclofen extended release - Sun Pharma Advanced Research Company

Drug Profile

Baclofen extended release - Sun Pharma Advanced Research Company

Alternative Names: Baclofen ER capsules - Sun Pharma Advanced Research Company; Baclofen GRS

Latest Information Update: 22 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Aminobutyric acids; Antispastics; Muscle relaxants; Small molecules
  • Mechanism of Action GABA B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Muscle spasticity
  • Suspended Alcoholism

Most Recent Events

  • 28 Apr 2017 Sun Pharma Advanced Research Company completes a phase II trial for Muscle spasticity in USA, Russia and Ukraine (NCT02027025)
  • 05 Feb 2016 Baclofen extended release is still in phase III trials for Spasticity in USA
  • 10 Jun 2015 Discontinued - Preclinical for Alcoholism in European Union (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top